News + Font Resize -

Li-Taka Pharmaceuticals abandon the rights issue
Our Bureau, Mumbai | Tuesday, August 2, 2005, 08:00 Hrs  [IST]

Li-Taka Pharmaceuticals Ltd has decided to abandon the rights issue due to the inordinate delay in getting approval from SEBI to the Draft Letter of Offer. The company also decided to amalgamate Care Unipac Pvt Ltd with the company after certain approvals.

Gopal Ramourti appointed as Joint Managing Director of the Company for a period of 5 years w.e.f. August 01, 2005 and the company is getting necessary approvals for the same in due course.

Post Your Comment

 

Enquiry Form